We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. Although we may acquire a business in any industry, we intend to focus […]

  We are a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. With our product candidates, we aim to provide rapid cognitive improvement and alter the course of neurological diseases with our novel mechanism of action. Our approach is designed to augment neuronal growth factor signaling through […]

(Note:  This is not a traditional IPO. This is a direct listing of our Class A common stock on the New York Stock Exchange without the involvement of any investment bank.  From the prospectus: “We have engaged Morgan Stanley & Co. LLC, or Morgan Stanley; J.P. Morgan Securities LLC, or J.P. Morgan; Credit Suisse Securities […]

  Ribbit LEAP, Ltd., which stands for Ribbit Capital Long-Term Equity Acquisition Pool, is a newly organized blank check company incorporated in the Cayman Islands.  While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus our search for an initial business combination in the intersection of financial […]

(Note: Cohn Robbins Holdings Corp. was formerly known as CSR Acquisition Corp.. which was a newly organized blank check company that had filed to go public on July 31, 2020; that IPO was 30 million units at $10 each. The name change is disclosed in the S-1/A filing on Aug. 25, 2020. In this filing, […]

  We are building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. We are utilizing our proprietary FORCE platform to overcome the current limitations of muscle tissue delivery and advance modern oligonucleotide therapeutics for muscle diseases. Using our FORCE platform, we are assembling a broad portfolio […]

While we may pursue an initial business combination in any industry, we intend to focus our efforts on businesses that leverage our management team’s experience in acquiring and operating businesses in the consumer (“Consumer”) as well as technology, media and telecommunications (“TMT”) industries. We intend to focus our efforts and will seek to capitalize on […]

(Note: This is not a traditional IPO. This is a direct listing of Palantir’s Class A common stock on the New York Stock Exchange without the involvement of underwriters. From the prospectus: “We have engaged Morgan Stanley & Co. LLC (“Morgan Stanley”), Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, Allen & Company […]

Good Works Acquisition Corp. is a newly organized blank check company. We intend to initially focus our search on identifying a prospective target business that has experienced financial distress or has recently emerged from a financial restructuring. Our name, Good Works, embodies our secondary objective. Our company, through three of our officers and directors, has […]

  We are a newly organized blank check company. While we may pursue an initial business combination with a company in any sector, we intend to focus our search on the consumer sector and consumer-related businesses, which complements the expertise of our management team, directors and advisors. Ken Suslow is the CEO and chairman. Designer […]